These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Activity of glycopeptides against vancomycin-resistant gram-positive bacteria. Nicas TI, Cole CT, Preston DA, Schabel AA, Nagarajan R. Antimicrob Agents Chemother; 1989 Sep; 33(9):1477-81. PubMed ID: 2817848 [Abstract] [Full Text] [Related]
13. Cloning and heterospecific expression of the resistance determinant vanA encoding high-level resistance to glycopeptides in Enterococcus faecium BM4147. Brisson-Noël A, Dutka-Malen S, Molinas C, Leclercq R, Courvalin P. Antimicrob Agents Chemother; 1990 May; 34(5):924-7. PubMed ID: 2360831 [Abstract] [Full Text] [Related]
14. Effect of growth phase and pH on the in vitro activity of a new glycopeptide, oritavancin (LY333328), against Staphylococcus aureus and Enterococcus faecium. Mercier RC, Stumpo C, Rybak MJ. J Antimicrob Chemother; 2002 Jul; 50(1):19-24. PubMed ID: 12096002 [Abstract] [Full Text] [Related]
15. Transferable vancomycin and teicoplanin resistance in Enterococcus faecium. Leclercq R, Derlot E, Weber M, Duval J, Courvalin P. Antimicrob Agents Chemother; 1989 Jan; 33(1):10-5. PubMed ID: 2523687 [Abstract] [Full Text] [Related]
16. Replacement of the essential penicillin-binding protein 5 by high-molecular mass PBPs may explain vancomycin-beta-lactam synergy in low-level vancomycin-resistant Enterococcus faecium D366. al-Obeid S, Billot-Klein D, van Heijenoort J, Collatz E, Gutmann L. FEMS Microbiol Lett; 1992 Feb 01; 70(1):79-84. PubMed ID: 1577257 [Abstract] [Full Text] [Related]
17. A comparison of the responses of staphylococci and streptococci to teicoplanin and vancomycin. Greenwood D, Bidgood K, Turner M. J Antimicrob Chemother; 1987 Aug 01; 20(2):155-64. PubMed ID: 2959642 [Abstract] [Full Text] [Related]
18. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. Leclercq R, Derlot E, Duval J, Courvalin P. N Engl J Med; 1988 Jul 21; 319(3):157-61. PubMed ID: 2968517 [No Abstract] [Full Text] [Related]
19. In vitro activity of oritavancin and comparator agents against staphylococci, streptococci and enterococci from clinical infections in Europe and North America, 2011-2014. Biedenbach DJ, Arhin FF, Moeck G, Lynch TF, Sahm DF. Int J Antimicrob Agents; 2015 Dec 21; 46(6):674-81. PubMed ID: 26541881 [Abstract] [Full Text] [Related]
20. Effect of quinupristin/dalfopristin alone or in combination with vancomycin on the structure of Enterococcus faecium. Lorian V, Fernandes F. Drugs Exp Clin Res; 1998 Dec 21; 24(2):73-6. PubMed ID: 9675547 [Abstract] [Full Text] [Related] Page: [Next] [New Search]